Literature DB >> 29677357

Optical Coherence Tomography Minimum Intensity as an Objective Measure for the Detection of Hydroxychloroquine Toxicity.

Ali M Allahdina1, Paul F Stetson2, Susan Vitale1, Wai T Wong1, Emily Y Chew1, Fredrick L Ferris1, Paul A Sieving1, Catherine Cukras1.   

Abstract

Purpose: As optical coherence tomography (OCT) minimum intensity (MI) analysis provides a quantitative assessment of changes in the outer nuclear layer (ONL), we evaluated the ability of OCT-MI analysis to detect hydroxychloroquine toxicity.
Methods: Fifty-seven predominantly female participants (91.2% female; mean age, 55.7 ± 10.4 years; mean time on hydroxychloroquine, 15.0 ± 7.5 years) were enrolled in a case-control study and categorized into affected (i.e., with toxicity, n = 19) and unaffected (n = 38) groups using objective multifocal electroretinographic (mfERG) criteria. Spectral-domain OCT scans of the macula were analyzed and OCT-MI values quantitated for each subfield of the Early Treatment Diabetic Retinopathy Study (ETDRS) grid. A two-sample U-test and a cross-validation approach were used to assess the sensitivity and specificity of toxicity detection according to OCT-MI criteria.
Results: The medians of the OCT-MI values in all nine of the ETDRS subfields were significantly elevated in the affected group relative to the unaffected group (P < 0.005 for all comparisons), with the largest difference found for the inner inferior subfield (P < 0.0001). The receiver operating characteristic analysis of median MI values of the inner inferior subfields showed high sensitivity and high specificity in the detection of toxicity with area under the curve = 0.99. Conclusions: Retinal changes secondary to hydroxychloroquine toxicity result in increased OCT reflectivity in the ONL that can be detected and quantitated using OCT-MI analysis. Analysis of OCT-MI values demonstrates high sensitivity and specificity for detecting the presence of hydroxychloroquine toxicity in this cohort and may contribute additionally to current screening practices.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29677357      PMCID: PMC5894928          DOI: 10.1167/iovs.17-22668

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  29 in total

Review 1.  Ocular safety of hydroxychloroquine.

Authors:  H N Bernstein
Journal:  Ann Ophthalmol       Date:  1991-08

Review 2.  ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition).

Authors:  Donald C Hood; Michael Bach; Mitchell Brigell; David Keating; Mineo Kondo; Jonathan S Lyons; Michael F Marmor; Daphne L McCulloch; Anja M Palmowski-Wolfe
Journal:  Doc Ophthalmol       Date:  2011-10-30       Impact factor: 2.379

3.  STS-MIP: a new reconstruction technique for CT of the chest.

Authors:  S Napel; G D Rubin; R B Jeffrey
Journal:  J Comput Assist Tomogr       Date:  1993 Sep-Oct       Impact factor: 1.826

4.  Subjective and objective screening tests for hydroxychloroquine toxicity.

Authors:  Catherine Cukras; Nancy Huynh; Susan Vitale; Wai T Wong; Fredrick L Ferris; Paul A Sieving
Journal:  Ophthalmology       Date:  2014-10-14       Impact factor: 12.079

5.  Spectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescence.

Authors:  S Kellner; S Weinitz; U Kellner
Journal:  Br J Ophthalmol       Date:  2009-08-18       Impact factor: 4.638

6.  Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.

Authors:  David J Browning
Journal:  Am J Ophthalmol       Date:  2012-12-04       Impact factor: 5.258

7.  Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).

Authors:  Michael F Marmor; Ulrich Kellner; Timothy Y Y Lai; Ronald B Melles; William F Mieler
Journal:  Ophthalmology       Date:  2016-03-16       Impact factor: 12.079

Review 8.  Ocular toxicity of hydroxychloroquine.

Authors:  Rodney Tehrani; Rochella A Ostrowski; Richard Hariman; Walter M Jay
Journal:  Semin Ophthalmol       Date:  2008 May-Jun       Impact factor: 1.975

9.  Fully Automated Prediction of Geographic Atrophy Growth Using Quantitative Spectral-Domain Optical Coherence Tomography Biomarkers.

Authors:  Sijie Niu; Luis de Sisternes; Qiang Chen; Daniel L Rubin; Theodore Leng
Journal:  Ophthalmology       Date:  2016-06-01       Impact factor: 12.079

10.  Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the "flying saucer" sign).

Authors:  Eric Chen; David M Brown; Matthew S Benz; Richard H Fish; Tien P Wong; Rosa Y Kim; James C Major
Journal:  Clin Ophthalmol       Date:  2010-10-21
View more
  3 in total

1.  Visual Field Sensitivity Prediction Using Optical Coherence Tomography Analysis in Hydroxychloroquine Toxicity.

Authors:  Gopal Jayakar; Tharindu De Silva; Catherine A Cukras
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-01-03       Impact factor: 4.799

2.  A Novel Approach to Quantitative Evaluation of Outer Retinal Lesions Via a New Parameter "Integral" in Spectral Domain Optical Coherence Tomography.

Authors:  Junxiang Gu; Tingting Jiang; Mingrong Yu; Jian Yu; Wenting Li; Shixue Liu; Peijun Zhang; Wenwen Chen; Qing Chang
Journal:  Transl Vis Sci Technol       Date:  2020-11-02       Impact factor: 3.283

3.  Quantitative Fundus Autofluorescence in Systemic Chloroquine/Hydroxychloroquine Therapy.

Authors:  Clara Reichel; Andreas Berlin; Victoria Radun; Ioana-Sandra Tarau; Jost Hillenkamp; Nikolai Kleefeldt; Kenneth R Sloan; Thomas Ach
Journal:  Transl Vis Sci Technol       Date:  2020-08-28       Impact factor: 3.283

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.